Given that this increased migration activity was suppressed by the VEGFR2 inhibitor Ki8751 pretreatment (Figure 3), we are convinced that VEGF is the key molecule in epithelial and endothelial cell communication during IL-17C signaling in tumor angiogenesis. This evidence concerns the gene KDR and neoplasm.